Skip to main content

Table 1 Gene alterations in tumor samples

From: Genetic profiling of patients with adenoid cystic carcinoma of the Bartholin’s glands reveals potential new routes for targeted therapies: a case report

Case

Gene alteration

VAF (%)

CN

Pathogenicity

1

KRAS G12D

12.4

2.20

Pathogenic

2

KDM6A c.2832 + 1G > C

41.9

2.06

Pathogenic

  1. VAF Variant allele frequency, CN Copy number.